Removal of the Translocation Domain and the Furin Cleavage Site Decreases the Relative Hepatotoxicity of the Targeted Antitumor Toxins.
Targeted toxins are promising anticancer agents that allow selectively destroying cancer cells due to the increased content of onco-specific markers on their surface. The use of such anti-cancer toxins in medicine is mainly hampered by their high non-specific toxicity, in particular, hepatotoxicity. In our work on human cell line, we have shown that the removal of the DARPin-PE40 translocation toxin domain leads to a decrease in hepatotoxicity. The same effect is also observed when inactivation of the furin cleavage site in the DARPin-PE40 molecule was done. Simultaneous removal of both the translocation domain and the furin cleavage site showed the best results. This toxin modification can be used to create more selective anti-cancer toxins.
: 
: 32130602
Список научных проектов, где отмечена публикация
- - (January 6, 2018 — December 31, 2020). . Grant, RFBR.
- - (March 21, 2018 — April 9, 2020). . Grant, RFBR.
- Development of an address system based on anti-HER2 scaffolds and a barnase-barstar molecular pair for the multistep delivery of cytotoxins in the treatment of HER2-positive malignant tumors. (January 6, 2019 — December 31, 2023). . Grant, RSF.